ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Ann Thorac Surg 2008;85:361. doi:10.1016/j.athoracsur.2007.07.072
© 2008 The Society of Thoracic Surgeons
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Warkentin, T. E.
Right arrow Articles by Koster, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Warkentin, T. E.
Right arrow Articles by Koster, A.
Related Collections
Right arrow Mechanical Circulatory Assistance
Right arrowRelated Article

Correspondence

Reply

Theodore E. Warkentin, MDa, Mark A. Crowther, MDb, Andreas Koster, MDc

a Department of Pathology and Molecular Medicine, McMaster University, 120 Main St West, Hamilton, Ontario, LBN 3Z5 Canada
b Department of Medicine, McMaster University, 120 Main St West, Hamilton, Ontario, LBN 3Z5 Canada
c Department of Anesthesia, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, Berlin, D-13353 Germany

(Email: twarken@mcmaster.ca; crowthrm@mcmaster.ca; koster@dhzb.dc).

The first 20% of the full text of this article appears below.

To the Editor:


Dr Warkentin discloses that he has a financial relationship with The Medicines Company.

 

We thank Barzaghi and colleagues [1], for responding to the article of Koster and colleagues [2] reporting on an observational study of patients with immune heparin-induced thrombocytopenia (HIT) in association with use of a ventricular assist device (VAD), and to the accompanying editorial [3] addressing the difficulties of accurate laboratory diagnosis of HIT in this patient population. Barzaghi and colleagues [1] point out that the more diagnostically specific platelet activation assays (eg, serotonin-release assay) are not widely available; therefore, "in [the] presence of . . . [Full Text of this Article]


Related Article

Ventricular Assist Device Implantation and the Risk for Heparin-Induced Thrombocytopenia
Nicoletta Barzaghi, Alessandro Locatelli, and Marco Ranucci
Ann. Thorac. Surg. 2008 85: 360-361. [Extract] [Full Text] [PDF]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The Society of Thoracic Surgeons.